Ashish M. Kamat MD Anderson Cancer Center

Ashish M. Kamat, M.D., MBBS, Department of Urology, Division of Surgery

Ashish Kamat, MD on LinkedIn: #asco23 #bladdercancer

Are Molecular Markers for Bladder Cancer Ready for Prime Time?

Therapeutic Selection, Safety, and Sequencing Along the Bladder Cancer Disease Continuum

Dr. Ashish M. Kamat - School of Medicine - LSU Health Sciences

Arlene O Siefker-Radtke MD Anderson Cancer Center

Have you downloaded our “Oncology Today with Dr Neil Love” podcast in the app store? In the latest episode, Dr Ashish Kamat from MD Anderson Cancer, By Research To Practice

60 Years of Survival Outcomes at The University of Texas MD Anderson Cancer Center

Q&A: Urologic oncologist Ashish M. Kamat discusses his COVID-19 research – The Review

Société Internationale d'Urologie (SIU) - SIU's #B2BGUCancerTriad #FacultyFeature: Scientific Programme Committee Member, Dr Ashish Kamat. Follow the link to register for free

Ashish M. Kamat, MD, MBBS (@UroDocAsh) / X

Dr. Ashish Kamat, MD – Houston, TX

BCG in Bladder Cancer Treatment

Ashish M. Kamat, MD, MBBS (@UroDocAsh) / X

Ashish M. Kamat MD Anderson Cancer Center

Dr. Kamat on a Molecular Definition of BCG Failure